Drugs Made In America Acquisition Corp. (DMAAR) › Shareholders' EquityDrugs Made In America Acquisition Corp. (DMAAR) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2024: -$244.8K2025: -$7.26M-$7.26M2024Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$7.26M-2866.8%2024-$244.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share